Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dual immunomodulation by met-enkephalin.

R R Rowland1, S Tokuda

  • 1Department of Microbiology, School of Medicine, University of New Mexico, Albuquerque 87131.

Brain, Behavior, and Immunity
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaussian process regression for thermal transport analysis in infrared imaging video bolometry.

The Review of scientific instruments·2026
Same author

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer.

ESMO open·2026
Same author

Bayesian inference of ion velocity distribution function from laser-induced fluorescence spectra.

Scientific reports·2021
Same author

A multiplex fluorescence microsphere immunoassay for increased understanding of Rift Valley fever immune responses in ruminants in Kenya.

Journal of virological methods·2019
Same author

Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.

Journal of clinical microbiology·2018
Same author

The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

Genes and immunity·2015

Met-enkephalin (MENK) true immune modulation occurs only with strong immune signals. MENK suppressed strong responses but overcame high-antigen suppression, demonstrating context-dependent immune regulation.

Area of Science:

  • Immunology
  • Neuroendocrinology
  • Peptide Signaling

Background:

  • Met-enkephalin (MENK), an opioid peptide, influences immune responses during stress.
  • Previous studies indicated MENK's ability to modulate the plaque-forming cell (PFC) response.
  • The exact conditions for MENK's immunomodulatory effects remained unclear.

Purpose of the Study:

  • To investigate the precise conditions under which MENK modulates immune function.
  • To determine if MENK's effects are dose-dependent on the immune signal strength.
  • To characterize MENK's role in regulating the plaque-forming cell (PFC) response.

Main Methods:

  • Utilized Mishell-Dutton cultures with splenocytes.
  • Challenged cultures with incremental concentrations of sheep erythrocyte (SE) antigen.

Related Experiment Videos

  • Assessed the plaque-forming cell (PFC) response in the presence of 10(-7) M MENK.

    • Main Results:

    • MENK demonstrated true immunomodulation, acting only during strong immune signals.
    • MENK suppressed the PFC response when the immune signal was strong.
    • MENK overcame high-antigen-induced suppression, enhancing the PFC response above optimal levels.
    • MENK had no significant effect when the immune signal was weak (insufficient antigen).

    Conclusions:

    • MENK's immunomodulatory capacity is contingent on the strength of the immune stimulus.
    • MENK exhibits context-dependent regulation, suppressing strong responses and boosting suppressed ones.
    • These findings clarify the specific conditions for MENK's role in immune function.